References
- Erspamer V, Asero B. Identification of enteramine, the specific hormone of the enterochromaffin cell system as 5-hydroxy-tryptamine. Nature 1952; 169: 800–1
- Gershon M D., Tamir H. Release of endogenous 5-hydroxy-tryptamine from resting and stimulated enteric neurons. Neuro-science 1981; 6: 2277–86
- Santini R, Roche M, Laugier C, et al. Etude biochimique compareée du tractus digestif chez les memmifères. C R Soc Biol (Paris) 1971; 165: 1671
- Bulbring E, Gershon M D. 5-hydroxytryptamine participation in the vagal inhibitory innervation of stomach. J Physiol (Lond) 1976; 192: 823–46
- Costa M, Furness J B. The sites of action of 5-hydroxytryptamine in nerve-muscle preparations from the guinea pig small intestine and colon. Br J Pharmacol 1979; 65: 237–48
- Wood J, Mayer C J. Slow synaptic excitation mediated by serotonin in Auerbach's plexus. Nature 1978; 276: 836–7
- Rothman T P., Ross L, Gershon M D. Separately developing axonal uptake of 5-hydroxytryptamine and norepinephrine in the fetal ileum of the rabbit. Brain Res 1976; 115: 437–56
- Wood J D. Enteric neurophysiology. Am J Physiol 1984; 247: G585–98
- Leander S R., Ekman R, Uddman R, Sundler F, Hakanson R. Neuronal cholecystokinin, gastrin-releasing peptide neurotensin and β-endorphin in the intestine of the guinea-pig. Distribution and possible motor functions. Cell Tissue Res 1984; 235: 521–31
- Eysselein V E., Reeve J R., Shively J E. Partial structure of a large canine cholecystokinin (CCK-58): amino acid sequence. Peptides 1982; 3: 687–91
- Liddle R A., Goldfine I D., Williams J A. Bioassay of cholecystokinin in rats: effects of food, trypsin inhibitor and alcohol. Gastroenterology 1984; 87: 542–9
- Eysselein V E., Eberlein G A., Grandt M., Schaeffer D, Niebel H., Goebel W., et al. Characterization of the major form of cholecystokinin in human intestine: CCK-58. Am J Physiol 1990; 258: G253–60
- Walsh J H. Endocrine cells of the digestive system. Physiology of the gastrointestinal tract, L R. Johnson. Raven, New York 1981; 59–143
- Due F. Contribution à ľ étude du contrôle hormonal sur la motricité duodénale chez le rat. Rôle privilégié de la cholé-cystokinine [dissertation], University of Lyons, Lyons 1988
- Liberge M, Arruebo M P., Bueno L. CCK8 neurons of the ventromedical (VMH) hypothalamus mediated the upper gut motor changes associated with feeding in rats. Brain Res 1990; 508: 118–23
- Liberge M, Arruebo M P., Bueno L. Role of hypothalamic cho-lecystokinin octapeptide in the colonic motor response to a meal in rats. Gastroenterology 1991; 100: 441–9
- Gue M, Bueno L. Brain CCK A receptors mediate the colonic motor response to feeding in dogs. Peptides 1991; 12: 523–7
- Snape W J., Jr, Matarazzo S A., Cohen S. Effect of eating and gastrointestinal hormones on human colonic myoelectrical and motor activity. Gastroenterology 1978; 75: 373–8
- Wiley J, Owyang C. Participation of serotonin and substance P in the action of cholecystokinin on colonic motility. Am J Physiol 1987; 252: G431–5
- Roche M, Santini R. Etude électrophysiologique de la motricité gastrique. Electromyographic. C R Soc Biol (Paris) 1970; 164: 1528–34
- Latour A. Un dispositif simple ď analyse quantitative de ľ électromyogramme intestinal chronique. Ann Rech Vet 1973; 4: 347–53
- Lotti V J., Pendleton R G., Gould R J., et al. In vivo pharmacology of L-364,718, a new potent nonpeptide peripheral cholecystokinin antagonist. J Pharmacol Exp Ther 1987; 241: 103–9
- Klosla S, Crawley J N. Potency of L364,718 as an antagonist of the behavioral effects of peripherally administrated cholecystokinin. Life Sci 1988; 42: 153–9
- Lotti V J., Chang R SL. A new potent and selective nonpeptide gastrin antagonist and brain cholecystokinin receptor (CCK B) ligand: L365,260. Eur J Pharmacol 1989; 162: 273–80
- Ruckebush Y, Fioramonti J. Electrical spiking activity and propulsion in the small intestine in fed and fasted rats. Gastroenterology 1975; 68: 1500–8
- Du C. Motricité du colon chez le rat. Nature et controle med-ullaire. [dissertation], University of Toulouse, Toulouse 1986
- Ruckebush Y, Fioramonti J. Colonic myolectrical spiking activity: major pattern and significance in six different species. Zentralbe Veterinaermed [A] 1980; 27: 1–8
- Talley N J., Phillips S F., Haddad A, et al. Effect of selective 5HT3 antagonist (GR 38032 F) on small intestinal transit and release of gastrointestinal peptides. Dig Dis Sci 1989; 34: 1511–5
- Richter G, Stockman F, Conlon J M., et al. Serotonin release into blood after food and pentagastrin. Studies in healthy subjects and in patients with metastatic carcinoid tumors. Gastroenterology 1986; 91: 612–8
- Moran T H., Robinson P, Goldrich M S., Mc Hugh P. Two brain cholecystokinin receptors: implications for behavioral actions. Brain Res 1986; 362: 175–9
- Lin C W., Holladay M W., Barrett R W., Wolfram C AW, Miller T R., Witte D, et al. Distinct requirements for activation at CCK-A and CCK-B/gastrin receptors: studies with a C-terminal hydrazide analogue of cholecystokinin tetrapeptide (30–33). Mol Pharmacol 1989; 36: 881–6
- Lüttichau H R., Solinger W WV, Nielsen F C., Rehfeld J F. Developmental expression of the gastrin and cholecystokinin genes in rat colon. Gastroenterology 1993; 104: 1092–8